Phase 1 study: New medicine extends t... - Advanced Prostate...

Advanced Prostate Cancer

22,075 members27,703 posts

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

rsgdmd profile image
8 Replies

mdlinx.com/news/phase-1-stu...

Written by
rsgdmd profile image
rsgdmd
To view profiles and participate in discussions please or .
8 Replies
6357axbz profile image
6357axbz

I don’t think it states which cancer it was effective on

rsgdmd profile image
rsgdmd in reply to 6357axbz

No, it sounded like it was, perhaps, universal?

6357axbz profile image
6357axbz in reply to rsgdmd

we can hope

MarkEmrys profile image
MarkEmrys

clinicaltrials.gov/ct2/show...

Biobro profile image
Biobro

Says they are about to start testing it on Sarcomas and Ovarian Cancer

j-o-h-n profile image
j-o-h-n

Cancer Here, Cancer there................. Cancer everywhere makes me Swear (fucking Cancer).............. s

Good Luck, Good Health and Good Humor.

j-o-h-n Monday 03/27/2023 1:12 PM DST

Boywonder56 profile image
Boywonder56 in reply to j-o-h-n

As dr seus said....i dont like cancer here i dont like cancer there, i dont like cancer anywhere.....

Scout4answers profile image
Scout4answers

similar to most of the other drugs now available only 1 in 20 was cancer free at 2 years, for others it looks like the drug only worked for a short time.

Progress none the less. A cure is coming.

Not what you're looking for?

You may also like...

Phase 1-2 study for niclosamide-based drug:

…thought they made cars… 😜 “Hyundai’s formulation claims to have a high enough drug concentration...

PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177

Just had my 1st infusion of Lutetium- 177, 3/9/23, in the Eclipse Trial. Received 216.0 mCi of...

Second generation selective PARP inhibitor: PETRANHA: Phase 1/2 study of AZD5305 + novel hormonal agents in patients mPCa

...as I reported, one of the patients on the trial (with ATM mutation) had a 100% remission......

Phase 1 study SBRT for bone metastases in oligometastatic patients. So far, "few toxicity events and high local control rate"

stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients:...

JAMA October 2108 - Does Complementary Medicine Increase Risk of Death for Cancer Patients?

On a subject that consumes a lot of written space on any post that suggest alternative treatments...